TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01633957 — Predictive Biomarker (PRD): CYP4F2 mRNA
Genes: CYP4F2
Study NCT02160860 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02678494 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT02725125 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study NCT00061516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04182464 — Predictive Biomarker (PRD): TAS1R3 mRNA
Genes: TAS1R3; T1R3; TR3
Study NCT04182464 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT04182464 — Predictive Biomarker (PRD): SLC2A2 mRNA
Genes: SLC2A2; GLUT2
Study NCT04182464 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02494596 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05530057 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00893516 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04510389 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT04510389 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04612972 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01093703 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03482934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02711189 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00685256 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04343053 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03974022 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03974022 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02743611 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT03762304 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02312193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00767923 — Predictive Biomarker (PRD): TBP mRNA
Genes: TBP; GTF2D1; TF2D; TFIID
Study NCT00769288 — Predictive Biomarker (PRD): FAU mRNA
Genes: FAU
Study NCT00001301 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01619215 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03995329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03995329 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05605951 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT03307707 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00377780 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02125448 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01308411 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00660894 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02578563 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00716469 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01016873 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02909894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03037359 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02078180 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT02631902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00045032 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00343642 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT01445405 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01099514 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04460534 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04377113 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02584205 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT03871959 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04128488 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04863508 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00888355 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00085280 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00085280 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT02613221 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02613221 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT04123691 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01980485 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT03566940 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02996279 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study NCT01048970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01048970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01048970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04476017 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT03796715 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT02028169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01631669 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT02683148 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00444496 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01840046 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01840046 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT01840046 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00111774 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01522235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03720457 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03089307 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01912625 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04293744 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT04293744 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04293744 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study NCT04293744 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01171651 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00495157 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03183544 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00709956 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02756429 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02756429 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04497519 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT01905475 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02547961 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01757340 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02546414 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02672774 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT01250444 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04267900 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04567173 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02917018 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03154892 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03154892 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00408967 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT02333760 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00622895 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00622895 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04500704 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04500704 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04006626 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT01723644 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01961115 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT00060801 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03820778 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00536211 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT01267357 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03217253 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT03550300 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT00694278 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03154242 — Predictive Biomarker (PRD): ERCC5 mRNA
Genes: ERCC5; ERCM2; XPG; XPGC
Study NCT02214862 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02156466 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT01186952 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00730470 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT01189383 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT00116285 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT03383692 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01464281 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01709773 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01412892 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02643706 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT01907386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03708354 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03708354 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02156271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00003414 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00003414 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01247311 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01661842 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04659512 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00917956 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03006614 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02221492 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02706353 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05003297 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05003297 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT01446809 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01446809 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00550420 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04175470 — Predictive Biomarker (PRD): HOXA9 mRNA
Genes: HOXA9; HOX1G
Study NCT04175470 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02500017 — Predictive Biomarker (PRD): NES mRNA
Genes: NES; Nbla00170
Study NCT00472680 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00794326 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04214951 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05114772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03396770 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study NCT03396770 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT02808663 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00364715 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00364715 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02809040 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00667576 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03715673 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00831454 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00831454 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01483430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01665573 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study NCT04215016 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05055232 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05055232 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02030834 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00511394 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00646854 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT02140255 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00118456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00118456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00118456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02321293 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02321293 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04587401 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00219115 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01750814 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02835885 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01749384 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01749384 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06461598 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01486576 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01460082 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01460082 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03775538 — Predictive Biomarker (PRD): CDNF mRNA
Genes: CDNF; ARMETL1
Study NCT00067756 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT01527526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01242813 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01531595 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01531595 — Predictive Biomarker (PRD): RHOH mRNA
Genes: RHOH; ARHH; TTF
Study NCT02266173 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02266173 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00028652 — Safety Biomarker (SAF): Interleukin 12
Study NCT02323607 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03784690 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03835793 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02789813 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00012194 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT00561626 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study NCT02844062 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02844062 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02095626 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT00962949 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01819948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01819948 — Safety Biomarker (SAF): TGFB1
Genes: CED; TGFbeta
Study NCT03427268 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01073059 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01175005 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01175005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00316576 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04663490 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04663490 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04538768 — Predictive Biomarker (PRD): P4HB mRNA
Genes: P4HB; ERBA2L; PDI; PDIA1; PO4DB
Study NCT03364348 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03046147 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03061773 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03061773 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03061773 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT03061773 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01315366 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT01315366 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01315366 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT04801264 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00924040 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01062178 — Predictive Biomarker (PRD): SRM mRNA
Genes: SRM; SPS1; SRML1
Study NCT00166855 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02243228 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01255774 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01255774 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00434967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00976144 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00477516 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02037789 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT01853839 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01111305 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT01896206 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02789657 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03433781 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT04351139 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02909621 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00390624 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT03982550 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00600119 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT01270802 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT00420511 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01777672 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT02009241 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT03445247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02012530 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00924157 — Predictive Biomarker (PRD): IPP mRNA
Genes: IPP; KLHL27
Study NCT01389206 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01756456 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT03211572 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00548184 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00548184 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1